Table 3.

Nonhematologic adverse events

All gradesGrade 1Grade 2Grade 3Grade 4
Rash 82% 41% 5% 36% 0% 
Diarrhea 64% 50% 9% 5% 0% 
Fatigue 59% 45% 14% 0% 0% 
Infusion-related reaction 37% 14% 23% 0% 0% 
Nausea 32% 32% 0% 0% 0% 
Infection 28% 5% 23% 0% 0% 
Neoplasms 23% 0% 5% 18% 0% 
Arthralgia 19% 14% 0% 5% 0% 
Hyperbilirubinemia 19% 14% 5% 0% 0% 
ALT increased 19% 14% 5% 0% 0% 
AST increased 18% 18% 0% 0% 0% 
Headache 18% 18% 0% 0% 0% 
Constipation 14% 14% 0% 0% 0% 
Edema 14% 9% 5% 0% 0% 
Fever 14% 5% 9% 0% 0% 
Creatinine increased 9% 9% 0% 0% 0% 
Neuropathy 9% 9% 0% 0% 0% 
Hyperuricemia 9% 9% 0% 0% 0% 
Atrial flutter 5% 0% 0% 5% 0% 
Periorbital edema 5% 0% 0% 5% 0% 
Febrile neutropenia 5% 0% 0% 5% 0% 
All gradesGrade 1Grade 2Grade 3Grade 4
Rash 82% 41% 5% 36% 0% 
Diarrhea 64% 50% 9% 5% 0% 
Fatigue 59% 45% 14% 0% 0% 
Infusion-related reaction 37% 14% 23% 0% 0% 
Nausea 32% 32% 0% 0% 0% 
Infection 28% 5% 23% 0% 0% 
Neoplasms 23% 0% 5% 18% 0% 
Arthralgia 19% 14% 0% 5% 0% 
Hyperbilirubinemia 19% 14% 5% 0% 0% 
ALT increased 19% 14% 5% 0% 0% 
AST increased 18% 18% 0% 0% 0% 
Headache 18% 18% 0% 0% 0% 
Constipation 14% 14% 0% 0% 0% 
Edema 14% 9% 5% 0% 0% 
Fever 14% 5% 9% 0% 0% 
Creatinine increased 9% 9% 0% 0% 0% 
Neuropathy 9% 9% 0% 0% 0% 
Hyperuricemia 9% 9% 0% 0% 0% 
Atrial flutter 5% 0% 0% 5% 0% 
Periorbital edema 5% 0% 0% 5% 0% 
Febrile neutropenia 5% 0% 0% 5% 0% 

ALT, alanine transaminase; AST, aspartate transaminase.

Close Modal

or Create an Account

Close Modal
Close Modal